首页> 外文期刊>International Journal of Pharmaceutics >Increased microneedle-mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO prevention
【24h】

Increased microneedle-mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO prevention

机译:将微针介导的四甲基吡嗪递送到大脑,与冰片和离子电渗疗法相结合,用于MCAO预防

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this research was to improve transdermal delivery and distribution of tetramethylpyrazine (TMP) in the brain, by adding borneol (BN) and iontophoresis (ITP), and using microneedles (MN), to prevent middle cerebral artery occlusion (MCAO). BN was encapsulated into sulfobutylated-beta-cyclodextrin (BN-SBE-beta-CD), and then dispersed together with TMP. Four delivery groups were tested: passive (with no ITP and MN), ITP, MN, and MN combined with ITP (MN-ITP). In vitro transdermal fluxes of the drugs in those groups and in that corresponding order were 79.12 +/- 14.5, 395.43 +/- 12.37, 319.16 +/- 29.99, and 1018.07 +/- 108.92 mu g/cm(2) (for TMP), and 39.34 +/- 1.31, 202.81 +/- 53.56, 715.47 +/- 75.52, and 1088.60 +/- 53.90 mu g/cm(2) (for BN), respectively, which indicated that the use of MN-ITP greatly enhanced transdermal TMP and BN delivery compared to the other groups. The AUC(0-t) for the combined use of TMP and BN drugs was measured using two in vivo studies, cutaneous microdialysis and pharmacodynamic, yielding increased folds of 3.69 and 1.98 in ITP, 6.05 and 2.73 in MN, and 12.43 and 7.47 in MN-ITP groups, respectively, as compared to those in the passive group. In addition, the combined use of TMP and BN increased TMP distribution in the heart and the brain, indicated by TMP C-max of 1.76- and 1.59-fold higher (p < 0.05), and TMP AUC(0-t) of 1.50 times and 1.19-fold higher (p < 0.01), than with administration of TMP in absence of BN, respectively. The brain infarction area and IL-beta expression in the MCAO rat were significantly decreased in the MN-ITP group, compared with the control group (p < 0.05). In conclusion, combination of MN and ITP resulted in a synergistic enhancement of transdermal delivery and distribution of TMP in the brain, when in combination with BN, thereby significantly decreasing the infarct volumes and improving the neurological scores of MCAO.
机译:该研究的目的是通过添加冰片(BN)和离子电渗疗法(ITP),并使用微针(Mn),改善脑中致甲基吡嗪(TMP)的透皮递送和分布,并使用微针(MN),以防止中脑动脉闭塞(MCAO)。将BN包封成磺基甲基β-环糊精(BN-SBE-BETA-CD),然后与TMP分散在一起。测试了四组:被动(无ITP和Mn),ITP,Mn和Mn与ITP(MN-ITP)组合。这些组中药物的体外透皮助焊剂,并以相应的顺序为79.12 +/- 14.5,395.43 +/- 12.37,3195.43 +/- 12.37,319.16 +/- 29.99和1018.07 +/- 108.92 mu g / cm(2)(用于TMP )和39.34 +/- 1.31,202.81 +/- 53.56,715.47 +/- 75.52和1088.60 +/- 53.90 mu g / cm(2)(for bn),表明使用Mn-ITP与其他组相比,大大增强了透皮TMP和BN递送。使用两种体内研究,皮肤微透析和药物动力学测量组合使用TMP和BN药物的AUC(0-T),在ITP,6.05和2.73中产生3.69和1.98的增加倍,12.43和7.47与被动组中的那些相比,MN-ITP分别分别。此外,TMP和BN的组合使用增加了心脏和大脑的TMP分布,由TMP C-MAX的较高(P <0.05)和1.50的TMP AUC(0-T)表示为1.50次数和1.19倍以下(P <0.01),而不是在不存在BN的情况下施用TMP。与对照组相比,MN-ITP组在MCAO大鼠中的脑梗塞区域和IL-β表达显着降低(P <0.05)。总之,Mn和ITP的组合导致脑内透皮递送和脑中TMP分布的协同增强,从而与BN组合,从而显着降低了梗塞体积和改善MCAO的神经学评数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号